Cytisinicline

Smoking cessation

Manufacturer: Achieve Life Sciences
Regulatory submission: NDA resubmission planned for the fourth quarter of 2026
Launch: Anticipated after potential approval in the first half of 2027
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Approaches to treatment Current treatment options and standard of care

Digital interventions

1 evidence topic · 1 source

Digital adjuncts and self-management tools

“text messaging, smartphone apps, and internet programmes” (opens the source at this quote in a new tab)